ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Kintara Therapeutics, Inc.
0.0001
0.0000
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
0.0001
开:
0.0001
低:
0.0001
收:
0.0001
52周最高:
0.0001
52周最低:
0.0001
股本:
- -
流通股本:
- -
量比:
0.05
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
Kintara Therapeutics, Inc.盘中异动 临近午盘急速上涨5.02%
市场透视
·
2024/10/16
Kintara Therapeutics, Inc.盘中异动 股价大涨5.10%报0.208美元
市场透视
·
2024/10/15
Kintara Therapeutics, Inc.盘中异动 股价大跌5.17%报0.200美元
市场透视
·
2024/10/07
Kintara Therapeutics, Inc.盘中异动 急速下跌5.13%报0.194美元
市场透视
·
2024/09/30
Kintara Therapeutics, Inc.盘中异动 早盘急速下跌5.69%报0.164美元
市场透视
·
2024/09/23
Kintara Therapeutics, Inc.盘中异动 大幅下挫5.23%
市场透视
·
2024/09/20
Kintara Therapeutics, Inc.盘中异动 大幅拉升5.14%报0.184美元
市场透视
·
2024/09/19
Kintara Therapeutics, Inc.盘中异动 快速上涨5.76%报0.178美元
市场透视
·
2024/09/17
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DMPWW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMPWW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMPWW\",,,,,undefined,":{"symbol":"DMPWW","market":"US","secType":"STK","nameCN":"Kintara Therapeutics, Inc.","latestPrice":0.0001,"timestamp":1772571600000,"preClose":0.0001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"盘前交易","change":0,"latestTime":"03-03 16:00:00 EST 延时","open":0.0001,"high":0.0001,"low":0.0001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772634600000},"marketStatusCode":1,"adr":0,"exchange":"PINK","adjPreClose":0.0001,"volumeRatio":0.048888335153240536},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMPWW\",,,,,undefined,":{"symbol":"DMPWW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.048888335153240536,"shares":0,"dividePrice":0,"high":0.0001,"amplitude":0,"preClose":0.0001,"low":0.0001,"week52Low":0.0001,"pbRate":"--","week52High":0.0001,"institutionHeld":0,"latestPrice":0.0001,"eps":0,"divideRate":0,"volume":0,"delay":15,"open":0.0001,"prevYearClose":0.0001,"prevWeekClose":0.0001,"prevMonthClose":0.0001,"prevQuarterClose":0.0001,"fiveDayClose":0.0001,"twentyDayClose":0.0001,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMPWW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-16","symbol":"DMPWW","reason":null,"defaultRemindTime":1723815000000,"announcedDate":"2024-08-15","type":"delisting","dateTimestamp":1723780800000},{"date":"2022-05-13","symbol":"DMPWW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1652428800000,"name":null,"time":"盘前","dateTimestamp":1652414400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMPWW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMPWW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMPWW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2475910253","title":"Kintara Therapeutics, Inc.盘中异动 临近午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475910253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475910253?lang=zh_cn&edition=fundamental","pubTime":"2024-10-16 23:43","pubTimestamp":1729093393,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时43分,Kintara Therapeutics, Inc.股票出现波动,股价大幅拉升5.02%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。其相关个股中,180 Life Sciences Corp.、Korro Bio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大,180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为6212.38%、1091.10%、777.16%,振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.,振幅分别为633.55%、279.52%、126.58%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016234313ab6a930c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016234313ab6a930c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTRA","LENZ","DMPWW"],"gpt_icon":0},{"id":"2475568223","title":"Kintara Therapeutics, Inc.盘中异动 股价大涨5.10%报0.208美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475568223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475568223?lang=zh_cn&edition=fundamental","pubTime":"2024-10-15 22:34","pubTimestamp":1729002861,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时34分,Kintara Therapeutics, Inc.股票出现波动,股价快速上涨5.10%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Gritstone Bio, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为300.75%、194.88%、183.55%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Gritstone Bio, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为85.94%、33.15%、28.45%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015223421ab6a47ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015223421ab6a47ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTRA","BK4139","LENZ","DMPWW"],"gpt_icon":0},{"id":"2473105601","title":"Kintara Therapeutics, Inc.盘中异动 股价大跌5.17%报0.200美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473105601?lang=zh_cn&edition=fundamental","pubTime":"2024-10-07 21:31","pubTimestamp":1728307884,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时31分,Kintara Therapeutics, Inc.股票出现波动,股价快速下挫5.17%。截至发稿,该股报0.200美元/股,成交量15.4186万股,换手率0.28%,振幅0.00%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721312498e3ad70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721312498e3ad70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DMPWW","KTRA","BK4139"],"gpt_icon":0},{"id":"2471383315","title":"Kintara Therapeutics, Inc.盘中异动 急速下跌5.13%报0.194美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471383315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471383315?lang=zh_cn&edition=fundamental","pubTime":"2024-09-30 21:30","pubTimestamp":1727703044,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时30分,Kintara Therapeutics, Inc.股票出现波动,股价快速下挫5.13%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Prime Medicine, Inc.、Aeon Biopharma, Inc.涨幅较大,Aditxt, Inc.、Windtree Therapeutics, Inc.、Onconetix, Inc.较为活跃,换手率分别为24.08%、16.89%、13.72%,振幅较大的相关个股有Century Therapeutics, Inc.、Igc Pharma, Inc.、Lineage Cell Therapeutics, Inc.,振幅分别为9.32%、3.87%、3.14%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213045ab67270a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213045ab67270a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DMPWW","BK4139","KTRA"],"gpt_icon":0},{"id":"2469211486","title":"Kintara Therapeutics, Inc.盘中异动 早盘急速下跌5.69%报0.164美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469211486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469211486?lang=zh_cn&edition=fundamental","pubTime":"2024-09-23 21:32","pubTimestamp":1727098360,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时32分,Kintara Therapeutics, Inc.股票出现异动,股价大幅下挫5.69%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Pharmacyte Biotech, Inc.涨幅较大,Galmed Pharmaceuticals Ltd.、Black Diamond Therapeutics, Inc.、Scisparc Ltd.较为活跃,换手率分别为41.98%、26.22%、22.64%,振幅较大的相关个股有Pharmacyte Biotech, Inc.、Galmed Pharmaceuticals Ltd.、天演药业,振幅分别为18.52%、16.05%、13.14%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213240a1dbec3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923213240a1dbec3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","DMPWW","BK4139"],"gpt_icon":0},{"id":"2468462181","title":"Kintara Therapeutics, Inc.盘中异动 大幅下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468462181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468462181?lang=zh_cn&edition=fundamental","pubTime":"2024-09-20 22:11","pubTimestamp":1726841496,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时11分,Kintara Therapeutics, Inc.股票出现异动,股价大幅跳水5.23%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.93%。其相关个股中,Novabay Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大,Galmed Pharmaceuticals Ltd.、Novabay Pharmaceuticals, Inc.、Corbus Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为1492.75%、1341.84%、38.59%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Novabay Pharmaceuticals, Inc.,振幅分别为165.20%、64.74%、50.21%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221137ab64e56e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221137ab64e56e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTRA","LENZ","DMPWW"],"gpt_icon":0},{"id":"2468505179","title":"Kintara Therapeutics, Inc.盘中异动 大幅拉升5.14%报0.184美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468505179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468505179?lang=zh_cn&edition=fundamental","pubTime":"2024-09-19 22:31","pubTimestamp":1726756287,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时31分,Kintara Therapeutics, Inc.股票出现波动,股价大幅上涨5.14%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.09%。其相关个股中,Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Edgewise Therapeutics, Inc.涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃,换手率分别为3613.11%、636.52%、156.60%,振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为81.66%、78.69%、52.97%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091922312898e381e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091922312898e381e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTRA","DMPWW","LENZ"],"gpt_icon":0},{"id":"2468366180","title":"Kintara Therapeutics, Inc.盘中异动 快速上涨5.76%报0.178美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468366180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468366180?lang=zh_cn&edition=fundamental","pubTime":"2024-09-17 23:27","pubTimestamp":1726586870,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日23时27分,Kintara Therapeutics, Inc.股票出现波动,股价大幅上涨5.76%。Kintara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.77%。其相关个股中,Galmed Pharmaceuticals Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Igm Biosciences, Inc.涨幅较大,Galmed Pharmaceuticals Ltd.、Allarity Therapeutics, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为8400.42%、674.17%、141.91%,振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为151.16%、50.00%、44.44%。Kintara Therapeutics, Inc.公司简介:Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723275098e37cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091723275098e37cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DMPWW","BK4139","KTRA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}